Elisabetta Garavaglia
Elisabetta Garavaglia has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Cinzia Sala
Private Practice, Milan, Italy
2 shared publicationsGianluca Taccagni
Pathology Unit, San Raffaele Scientific Institute, Milan, Italy
2 shared publicationsMassimo Candiani
Obstetrics and Gynaecology Unit, San Raffaele Scientific Institute, Milan, Italy
2 shared publications- Massimo Candiani
Department of Obstetrics and Gynecology, IRCCS San Raffaele Hospital, Milan, Italy
2 shared publications - Adele Ulisse
San Raffaele Scientific Institute
1 shared publication Alberto Massirone
Agorà, Italian Scientific Society of Aesthetic Medicine, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 13, 399-410
First Use of Thermal Stabilized Hyaluronic Acid Injection in One-Year Follow-Up Patients with Genitourinary Syndrome
Objective: Evaluation of the impact of hyaluronan hybrid cooperative complex (HCC) injections in premenopausal and postmenopausal Italian women affected by vulvar-vaginal atrophy (VVA), one of the symptoms of genitourinary syndrome (GS), on self-reported quality-of-life, vaginal symptoms, and sexual activity, as well as treatment side-effects. Methods: We surveyed a sample of 26 women affected by VVA with follow-up at 6 and 12 months. Deep intradermal injections of HCC were delivered at 1-month intervals. Evaluation of the treatment impacting the VVA patients was assessed by three international validated questionnaires (Visual Analogic Scale, VAS; health-related quality-of-life test, SF12; Female Sexual Function Index, FSFI). The statistically significant differences between pre- and after-treatment responses have been assessed by Wilcoxon signed-rank test and repeated measures ANOVA test. Results: At 6– 12-month follow-up, general quality-of-life (SF12) did not show any significant improvement. On the contrary, VVA patients showed significant improvements of genital symptoms (VAS) and sexual function (FSFI). Global FSFI score increased by 58% and evidenced important satisfaction (P≤ 0.05). Conclusion: Vestibular HCC injection is an office, safe, fast, not expensive, and reproducible procedure effective in vulvar-vaginal atrophy. This study can be used as a pilot for future trials.
- 1 December 2020
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 13, 399-410
Open AccessFirst Use of Thermal Stabilized Hyaluronic Acid Injection in One-Year Follow-Up Patients with Genitourinary Syndrome
Objective: Evaluation of the impact of hyaluronan hybrid cooperative complex (HCC) injections in premenopausal and postmenopausal Italian women affected by vulvar-vaginal atrophy (VVA), one of the symptoms of genitourinary syndrome (GS), on self-reported quality-of-life, vaginal symptoms, and sexual activity, as well as treatment side-effects. Methods: We surveyed a sample of 26 women affected by VVA with follow-up at 6 and 12 months. Deep intradermal injections of HCC were delivered at 1-month intervals. Evaluation of the treatment impacting the VVA patients was assessed by three international validated questionnaires (Visual Analogic Scale, VAS; health-related quality-of-life test, SF12; Female Sexual Function Index, FSFI). The statistically significant differences between pre- and after-treatment responses have been assessed by Wilcoxon signed-rank test and repeated measures ANOVA test. Results: At 6– 12-month follow-up, general quality-of-life (SF12) did not show any significant improvement. On the contrary, VVA patients showed significant improvements of genital symptoms (VAS) and sexual function (FSFI). Global FSFI score increased by 58% and evidenced important satisfaction (P≤ 0.05). Conclusion: Vestibular HCC injection is an office, safe, fast, not expensive, and reproducible procedure effective in vulvar-vaginal atrophy. This study can be used as a pilot for future trials.
- 1 January 2018
- Published by Elsevier in Medical Hypotheses
- Vol. 110, 80-82
The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions
- 1 January 2018
- Published by Elsevier in Medical Hypotheses
- Vol. 110, 80-82
The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions
- Open Access
- 25 July 2017
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 4, 40
Fertility Preservation in Endometriosis Patients: Anti-Müllerian Hormone Is a Reliable Marker of the Ovarian Follicle Density
Objective: To analyze the ovarian reserve via measurement of follicular density and AMH in endometriosis patients participating to a clinical program of cortical ovarian cryopreservation. Design: Retrospective analysis of serum AMH levels and prospective investigation of ovarian follicle number. Setting: University Hospital. Patient(s): Two hundred and two women with endometriosis and 400 controls. Intervention(s): Blood samples and ovarian biopsies. Main Outcome Measure(s): Correlation of serum AMH levels and the number of non-growing follicles in the biopsied cortical tissues in endometriosis and control subjects, including age, type of AMH kit, and the laboratory performing the analysis as covariates. Result(s): AMH levels were shown to decrease with age in untreated endometriosis patients (P <1.0x10-5) but they were significantly lower in endometriosis compared to controls only in patients over 36 years old (P = 2.7x10-4). The AMH decrease was faster in endometriosis compared to controls (beta = 0.27, P = 4.0x10-4). Primordial follicle number decreased with the reduction of AMH levels in both cases and controls (beta = 0.3; P = 0.04). Conclusion(s): AMH is a reliable marker of ovarian reserve in endometriosis patients and it can predict follicular density in women undergoing ovarian tissue cryopreservation.
- 25 July 2017
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 4, 40
Open AccessFertility Preservation in Endometriosis Patients: Anti-Müllerian Hormone Is a Reliable Marker of the Ovarian Follicle Density
Objective: To analyze the ovarian reserve via measurement of follicular density and AMH in endometriosis patients participating to a clinical program of cortical ovarian cryopreservation. Design: Retrospective analysis of serum AMH levels and prospective investigation of ovarian follicle number. Setting: University Hospital. Patient(s): Two hundred and two women with endometriosis and 400 controls. Intervention(s): Blood samples and ovarian biopsies. Main Outcome Measure(s): Correlation of serum AMH levels and the number of non-growing follicles in the biopsied cortical tissues in endometriosis and control subjects, including age, type of AMH kit, and the laboratory performing the analysis as covariates. Result(s): AMH levels were shown to decrease with age in untreated endometriosis patients (P <1.0x10-5) but they were significantly lower in endometriosis compared to controls only in patients over 36 years old (P = 2.7x10-4). The AMH decrease was faster in endometriosis compared to controls (beta = 0.27, P = 4.0x10-4). Primordial follicle number decreased with the reduction of AMH levels in both cases and controls (beta = 0.3; P = 0.04). Conclusion(s): AMH is a reliable marker of ovarian reserve in endometriosis patients and it can predict follicular density in women undergoing ovarian tissue cryopreservation.
- Open Access
Human Endometrial Stromal Cells Are Highly Permissive To Productive Infection by Zika Virus
Zika virus (ZIKV) is a recently re-emerged flavivirus transmitted to humans by mosquito bites but also from mother to fetus and by sexual intercourse. We here show for the first time that primary human endometrial stromal cells (HESC) are highly permissive to ZIKV infection and support its in vitro replication. ZIKV envelope expression was detected in the endoplasmic reticulum whereas double-stranded viral RNA colocalized with vimentin filaments to the perinuclear region. ZIKV productive infection also occurred in the human T-HESC cell line with the induction of interferon-β (IFN-β) and of IFN-stimulated genes. Notably, in vitro decidualization of T-HESC with cyclic AMP and progesterone upregulated the cell surface expression of the ZIKV entry co-receptor AXL and boosted ZIKV replication by ca. 100-fold. Thus, endometrial stromal cells, particularly if decidualized, likely represent a crucial cell target of sexual virus transmission and a relevant source of ZIKV spreading to placental trophoblasts during pregnancy. AUTHOR SUMMARY: Infection by Zika virus (ZIKV), a flavivirus transmitted to humans by mosquito bites, has recently emerged as an important cause of neurological lesions in the fetal brain as women who become infected by ZIKV during pregnancy can transmit the virus to their fetus. In addition, routes of ZIKV transmission independent of mosquito bites have been also identified and include sexual transmission from both infected men and women to their partners, an aspect bearing great societal implications for ZIKV spread. These observations highlight the importance of the female reproductive tract in the establishment and/or spreading of the infection. In this regard, the endometrium is a highly dynamic tissue undergoing major histological changes during the menstrual cycle under the coordinated action of sexual hormones. In particular, progesterone drives the differentiation of human endometrial stromal cells towards decidualization, a process that is critical for fetal trophoblast invasion and placenta formation. We here report for the first time that both primary and immortalized human endometrial stromal cells are highly permissive to ZIKV infection and replication, particularly when in vitro decidualized by progesterone, suggesting that these cells could significantly contribute to vertical ZIKV transmission in utero during pregnancy but also to horizontal transmission by the sexual route.
Open AccessHuman Endometrial Stromal Cells Are Highly Permissive To Productive Infection by Zika Virus
Zika virus (ZIKV) is a recently re-emerged flavivirus transmitted to humans by mosquito bites but also from mother to fetus and by sexual intercourse. We here show for the first time that primary human endometrial stromal cells (HESC) are highly permissive to ZIKV infection and support its in vitro replication. ZIKV envelope expression was detected in the endoplasmic reticulum whereas double-stranded viral RNA colocalized with vimentin filaments to the perinuclear region. ZIKV productive infection also occurred in the human T-HESC cell line with the induction of interferon-β (IFN-β) and of IFN-stimulated genes. Notably, in vitro decidualization of T-HESC with cyclic AMP and progesterone upregulated the cell surface expression of the ZIKV entry co-receptor AXL and boosted ZIKV replication by ca. 100-fold. Thus, endometrial stromal cells, particularly if decidualized, likely represent a crucial cell target of sexual virus transmission and a relevant source of ZIKV spreading to placental trophoblasts during pregnancy. AUTHOR SUMMARY: Infection by Zika virus (ZIKV), a flavivirus transmitted to humans by mosquito bites, has recently emerged as an important cause of neurological lesions in the fetal brain as women who become infected by ZIKV during pregnancy can transmit the virus to their fetus. In addition, routes of ZIKV transmission independent of mosquito bites have been also identified and include sexual transmission from both infected men and women to their partners, an aspect bearing great societal implications for ZIKV spread. These observations highlight the importance of the female reproductive tract in the establishment and/or spreading of the infection. In this regard, the endometrium is a highly dynamic tissue undergoing major histological changes during the menstrual cycle under the coordinated action of sexual hormones. In particular, progesterone drives the differentiation of human endometrial stromal cells towards decidualization, a process that is critical for fetal trophoblast invasion and placenta formation. We here report for the first time that both primary and immortalized human endometrial stromal cells are highly permissive to ZIKV infection and replication, particularly when in vitro decidualized by progesterone, suggesting that these cells could significantly contribute to vertical ZIKV transmission in utero during pregnancy but also to horizontal transmission by the sexual route.
- Open Access
- 1 June 2015
- Vol. 13 (6) , 327-336
Adenomyosis and its impact on women fertility
Adenomyosis is a widespread disease affecting the reproductive period of women’s life. In the last ten years, different pathogenetic hypotheses have been proposed to explain the initiation and development of the disease. This article aims to present and discuss the most important pathophysiologic mechanisms underlying adenomyosis development in order to clarify the relationship between adenomyosis and infertility. A PubMed search was undertaken for English language literature using the MeSH terms ‘adenomyosis’, ‘infertility’, ‘treatment’, and ‘pathogenesis’. Although the exact etiology of adenomyosis is unknown, many theories have been proposed. We analysed the most important pathogenic theories expressed and evaluated the potential consequences on women fertility. A better comprehension of the adenomyosis pathogenesis has allowed realizing that adenomyosis may affect young women and may have a great impact on their fertility through different mechanisms. The understanding of these mechanisms helps to clarify the potential usefulness of current therapies.
- 1 June 2015
- Vol. 13 (6) , 327-336
Open AccessAdenomyosis and its impact on women fertility
Adenomyosis is a widespread disease affecting the reproductive period of women’s life. In the last ten years, different pathogenetic hypotheses have been proposed to explain the initiation and development of the disease. This article aims to present and discuss the most important pathophysiologic mechanisms underlying adenomyosis development in order to clarify the relationship between adenomyosis and infertility. A PubMed search was undertaken for English language literature using the MeSH terms ‘adenomyosis’, ‘infertility’, ‘treatment’, and ‘pathogenesis’. Although the exact etiology of adenomyosis is unknown, many theories have been proposed. We analysed the most important pathogenic theories expressed and evaluated the potential consequences on women fertility. A better comprehension of the adenomyosis pathogenesis has allowed realizing that adenomyosis may affect young women and may have a great impact on their fertility through different mechanisms. The understanding of these mechanisms helps to clarify the potential usefulness of current therapies.
- Open Access
- 19 June 2012
- Vol. 6 (2) , 131-134
Interstitial Pregnancy after In Vitro Fertilization and Embryo Transfer Following Bilateral Salpingectomy: Report of Two Cases and Literature Review
Ectopic pregnancy is defined as the implantation and development of an embryo outside the uterus. Its incidence has increased over the past two decades. We report two cases of interstitial pregnancy on a tubal stump following bilateral salpingectomy and in vitro fertilization (IVF) treatments. We emphasize the importance of total salpingectomy during surgery in order to avoid interstitial pregnancy, particularly in women undergoing IVF treatments.
- 19 June 2012
- Vol. 6 (2) , 131-134
Open AccessInterstitial Pregnancy after In Vitro Fertilization and Embryo Transfer Following Bilateral Salpingectomy: Report of Two Cases and Literature Review
Ectopic pregnancy is defined as the implantation and development of an embryo outside the uterus. Its incidence has increased over the past two decades. We report two cases of interstitial pregnancy on a tubal stump following bilateral salpingectomy and in vitro fertilization (IVF) treatments. We emphasize the importance of total salpingectomy during surgery in order to avoid interstitial pregnancy, particularly in women undergoing IVF treatments.
- 1 October 2010
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 20 (7) , 1197-1200
Treatment of Recurrent or Metastatic Low-Grade Endometrial Stromal Sarcoma
- 1 October 2010
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 20 (7) , 1197-1200
Treatment of Recurrent or Metastatic Low-Grade Endometrial Stromal Sarcoma